- Home
- NMRA vs AFRI Comparison
NMRA vs AFRI Comparison
Compare NMRA & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- AFRI
- Stock Information
- Founded
- NMRA 2019
- AFRI 1943
- Country
- NMRA United States
- AFRI Gibraltar
- Employees
- NMRA N/A
- AFRI N/A
- Industry
- NMRA
- AFRI Packaged Foods
- Sector
- NMRA
- AFRI Consumer Staples
- Exchange
- NMRA Nasdaq
- AFRI Nasdaq
- Market Cap
- NMRA 121.0M
- AFRI 210.6M
- IPO Year
- NMRA 2023
- AFRI N/A
- Fundamental
- Price
- NMRA $1.26
- AFRI $7.79
- Analyst Decision
- NMRA Buy
- AFRI
- Analyst Count
- NMRA 8
- AFRI 0
- Target Price
- NMRA $9.29
- AFRI N/A
- AVG Volume (30 Days)
- NMRA 1.6M
- AFRI 17.4K
- Earning Date
- NMRA 08-05-2025
- AFRI 07-15-2025
- Dividend Yield
- NMRA N/A
- AFRI N/A
- EPS Growth
- NMRA N/A
- AFRI N/A
- EPS
- NMRA N/A
- AFRI N/A
- Revenue
- NMRA N/A
- AFRI $274,223,000.00
- Revenue This Year
- NMRA N/A
- AFRI N/A
- Revenue Next Year
- NMRA N/A
- AFRI N/A
- P/E Ratio
- NMRA N/A
- AFRI N/A
- Revenue Growth
- NMRA N/A
- AFRI N/A
- 52 Week Low
- NMRA $0.61
- AFRI $7.53
- 52 Week High
- NMRA $17.19
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- NMRA 69.27
- AFRI 45.77
- Support Level
- NMRA $0.72
- AFRI $7.67
- Resistance Level
- NMRA $1.18
- AFRI $7.92
- Average True Range (ATR)
- NMRA 0.10
- AFRI 0.16
- MACD
- NMRA 0.03
- AFRI 0.00
- Stochastic Oscillator
- NMRA 74.14
- AFRI 41.22
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.